Leaflet thrombosis after TAVI
Conditions
Interventions
Group 1: Within this unicenter prospective observational study, all patients with early diagnosed asymptomatic leaflet thrombosis on the TAVI prosthesis will be reexamined. 2 years after implantation
Sponsors
Universitätsherzzentrum Freiburg-Bad Krozingen
Eligibility
Sex/Gender
All
Age
59 Years to 100 Years
Inclusion criteria
Inclusion criteria: • Intervention at least 2 years ago • Existing post-interventional CT diagnostics during the implantation stay • Consent to participate in the study with CT implementation •> 59. age
Exclusion criteria
Exclusion criteria: Lack of consent • Oral anticoagulation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the quantitative measurement of possible calcification of the prosthetic cusps using CT. | — |
Secondary
| Measure | Time frame |
|---|---|
| -Density measurement of the prosthetic cusps derived from the CT. - Thickening or hypomobility of the cusps of the prosthesis. - Limitation of mobility of the prosthesis cups. - Deterioration of functional valve parameters in echocardiography (maximum speed, mean / maximum pressure gradient, speed quotient, aortic valve prosthesis opening area index, transvalvular and paravalvular insufficiency) - Clinical parameters such as stroke / TIA rate, systemic embolism, myocardial infarction, hospitalization for heart failure, syncope, NYHA status changes | — |
Countries
Germany
Contacts
Public ContactPhilipp Ruile
Klinik für Kardiologie und Angiologie IIUniversitätsherzzentrum Freiburg - Bad Krozingen
Outcome results
None listed